Observational Lung Cancer Registry Including NSCLC Stage III-IV and SCLC Stages

What this Trial Is About

Lung cancer is a serious condition affecting many people, with high mortality rates, particularly in Austria. This observational registry study is designed to collect and analyze data from patients diagnosed with lung cancer, including non-small cell lung cancer NSCLC and small cell lung cancer SCLC. The goal is to better understand patient characteristics, molecular testing, treatment patterns, and outcomes to improve personalized treatment strategies. This study collects routine medical and treatment information from patient charts without requiring additional diagnostic or therapeutic interventions. Data will be gathered from multiple centers and include longitudinal follow-up until patient death or loss to follow-up. No changes to patient treatment are made, as the study only observes and records existing care. Participants will have their medical data documented in an electronic registry with confidentiality maintained through unique patient identifiers. Researchers will assess various outcomes over 10 years, including treatment duration, frequency, response, sequence, survival overall survival and progression-free survival, and treatment toxicity. No extra procedures are required, and participation does not interfere with standard care.

Lung Cancer Registry